RECURSION PHARMACEUT

RXRX
Delayed Quote. Delayed  - 08/16 04:00:00 pm
12.32USD -4.94%

RECURSION PHARMACEUTICALS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)

06/21/2022 | 08:07am


Item 8.01 Other Events.


Press Release



On June 20, 2022, Recursion Pharmaceuticals, Inc. issued a press release
announcing the initiation of its Phase 2/3 POPLAR-NF2 trial for the treatment of
NF2-mutated meningiomas. A copy of the press release is attached hereto as
Exhibit 99.1.



Item 9.01 Financial Statements and Exhibits.





(d) Exhibits

Exhibit No. Description

99.1 Press Release, dated June 20, 2022.

104 Cover Page Interactive Data File (formatted as Inline XBRL)



--------------------------------------------------------------------------------

© Edgar Online, source Glimpses

© Acquiremedia 2022
Copier lien
All news about RECURSION PHARMACEUTICALS, INC.
5d ago
7d ago
7d ago
7d ago
7d ago